Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04082117 · ClinicalTrials.gov registry record · NA

Uptake of Genetic Counseling Among African American Women

A NA study of Breast Cancer Risk, sponsored by University of Illinois at Chicago.

Active
Registry status
NA
Development phase
960
Enrollment target
2
Study locations

NCT04082117: Active NA study of Breast Cancer Risk, sponsored by University of Illinois at Chicago.

NCT04082117 is a NA study of Breast Cancer Risk that is active but no longer recruiting, run by University of Illinois at Chicago. The registered enrollment target is 960 participants, below the 6,495-participant average among 4 other Breast Cancer Risk trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04082117, a NA study of Breast Cancer Risk, is active but no longer recruiting, sponsored by University of Illinois at Chicago.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
960 participants
Enrollment target
2
Study locations

Study Summary

A feasibility study incorporating an educational intervention with cancer genetic risk assessment (CGRA) in the UI Health mammography center

Primary Outcome

Change in knowledge of genetic counseling and intention to engage in genetic counseling following viewing of educational video based on response to survey designed by study investigators.

Conditions Studied

Breast Cancer Risk

Interventions

  • BEHAVIORAL Educational video

Study Locations (2)

Illinois

  • University of Illinois Health System - Chicago
  • University of Illinois - Chicago

Trial Details

FieldValue
Enrollment Target 960 participants
Start Date 2017-05-12
Est. Completion 2026-05
Phase NA
University of Illinois at Chicago

430 total trials

What the registry record for NCT04082117 still lists

NCT04082117 is an interventional study that assigns participants to a tested intervention. The registered 960 participants enrollment target is mid-sized for trials with a published cap, below the 6,495-participant average among 4 other Breast Cancer Risk trials with a reported enrollment target (85% lower).

The record links to 1 condition, with Breast Cancer Risk appearing as the primary indexed condition, and to 1 intervention - of which Educational video is the first listed.

NCT04082117 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04082117 about?

NCT04082117 is a clinical study titled "Uptake of Genetic Counseling Among African American Women". A feasibility study incorporating an educational intervention with cancer genetic risk assessment (CGRA) in the UI Health mammography center

What is the current status of trial NCT04082117?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 960 participants. The study started on 2017-05-12. Estimated completion is 2026-05.

What conditions does trial NCT04082117 study?

This clinical trial studies the following conditions: Breast Cancer Risk.

What interventions are being tested in trial NCT04082117?

The interventions under investigation include: Educational video (BEHAVIORAL).

Who is sponsoring clinical trial NCT04082117?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04082117 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer Risk

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04726241 · 960 participants · Phase 1

    The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • NCT05142384 · 960 participants · NA

    ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start

  • NCT05178498 · 960 participants

    Impact of Dietary Inflammatory Potential on Breast Cancer Risk

  • NCT05946629 · 960 participants · NA

    SELUTION 4 De Novo Small Vessel IDE Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04082117, the US trial registry maintained by the National Library of Medicine. NCT04082117 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.